GlassScriptPhysician profile
Kathleen Gotzmann
NPI 1740272228
$2,297.23
in general payments reported to CMS, 2019-2025
30 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $333 · 2021: $274 · 2022: $369 · 2023: $133 · 2024: $436 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $803.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $529.26 | 2019-2025 | |
| Astellas Pharma US INC | $247.01 | 2022-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $227.85 | 2019-2022 | |
| Hologic Sales and Service, LLC | $157.27 | 2019-2025 | Aptima, Fluent Fluid Management System, Omni Hysteroscope |
| Organon LLC | $112.59 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $110.78 | 2019-2023 | |
| Axonics, INC. | $99.54 | 2024 | Axonics |
| Therapeuticsmd, INC. | $96.59 | 2019-2021 | |
| Pfizer INC. | $76.61 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $74.93 | 2019-2021 | |
| Duchesnay USA Incorporated | $67.62 | 2019-2020 | |
| Medtronic, INC. | $56.57 | 2024 | Interstim |
| Minerva Surgical, INC | $48.05 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $42.32 | 2023-2025 | Gemtesa, Myfembree |
| Ethicon US, LLC | $35.18 | 2021-2025 | Stratafix |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $34.80 | 2022 | |
| Allergan, INC. | $33.67 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $29.44 | 2019 | |
| Covidien LP | $25.99 | 2019 | |
| Sage Therapeutics, LLC | $25.80 | 2024 | |
| Abbott Laboratories | $22.63 | 2023 | Proclaim |
| Myovant Sciences INC. | $20.25 | 2022 | |
| Evofem Biosciences, INC. | $19.68 | 2021 | |
| Mayne Pharma Commercial LLC | $19.26 | 2022 | |
| Lupin INC. | $17.99 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $15.79 | 2025 | |
| Medtronic Vascular, INC. | $15.55 | 2020 | |
| Amgen INC. | $15.42 | 2020 | |
| Millicent US INC | $13.41 | 2021 | |
| Meditrina | $5.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Gotzmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.